Analyst Consensus ?
ConsensusBuy20 ratings
Bullish1365.0%
Neutral630.0%
Bearish15.0%
FN2 Earnings Intelligence
CBRE Group, Inc. (CBRE) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Barclays | Overweight | Overweight | Maintain | Jul 28, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jun 30, 2026 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Apr 24, 2026 |
| UBS | Buy | Neutral | Upgrade | Feb 23, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Oct 7, 2025 |
| JP Morgan | Overweight | Overweight | Maintain | Aug 26, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Jul 24, 2025 |
| Jefferies | Buy | Hold | Upgrade | Jan 2, 2025 |
| Citigroup | Buy | Buy | Maintain | Nov 25, 2024 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 11, 2023 |
| Wolfe Research | Outperform | Outperform | Maintain | Mar 10, 2022 |
| CFRA | Sell | Hold | Downgrade | May 8, 2020 |
| Compass Point | Neutral | Neutral | Maintain | Jul 11, 2019 |
| Bank of America | Neutral | Buy | Downgrade | Jan 3, 2019 |
| B of A Securities | Neutral | Buy | Downgrade | Jan 3, 2019 |
| JMP Securities | Market Perform | Market Outperform | Downgrade | Jan 24, 2018 |
| Wedbush | Outperform | Outperform | Maintain | Oct 6, 2016 |
| Keefe Bruyette & Woods | Perform | Market Perform | Maintain | May 16, 2016 |
| Sterne Agee CRT | Buy | Buy | Maintain | Aug 26, 2015 |
| S&P Capital IQ | Hold | Buy | Downgrade | Aug 1, 2012 |
Upside is calculated against the persisted current price $147.78. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Barclays | Analyst unavailable | $180 | $143.88 | +21.8% | Jul 28, 2026 |
| Evercore ISI | Analyst unavailable | $169 | $136.05 | +14.4% | Jun 30, 2026 |
| Barclays | Analyst unavailable | $178 | $140.05 | +20.4% | May 5, 2026 |
| Evercore ISI | Analyst unavailable | $179 | $148.55 | +21.1% | Apr 24, 2026 |
| Barclays | Analyst unavailable | $175 | $145.94 | +18.4% | Apr 14, 2026 |
| UBS | Analyst unavailable | $185 | $147.01 | +25.2% | Feb 22, 2026 |
| Raymond James | Patrick O\'Shaughnessy | $180 | $133.87 | +21.8% | Feb 12, 2026 |
| Barclays | Analyst unavailable | $192 | $164.25 | +29.9% | Jan 13, 2026 |
| UBS | Analyst unavailable | $175 | $164.2 | +18.4% | Oct 24, 2025 |
| UBS | Alex Kramm | $165 | $152.46 | +11.7% | Oct 10, 2025 |
| Evercore ISI | Analyst unavailable | $185 | $164.98 | +25.2% | Aug 25, 2025 |
| Raymond James | Patrick O'Shaughnessy | $152 | $141.02 | +2.9% | Jan 24, 2025 |
| Evercore ISI | Steve Sakawa | $132 | $120.84 | -10.7% | Oct 4, 2024 |
| CFRA | Catherine Seifert | $115 | $111.22 | -22.2% | Jul 29, 2024 |
| Evercore ISI | Steve Sakawa | $123 | $109.37 | -16.8% | Jul 26, 2024 |
| Raymond James | Patrick O'Shaughnessy | $124 | $106.92 | -16.1% | Jul 25, 2024 |
| UBS | Alex Kramm | $95 | $87.08 | -35.7% | Jul 3, 2024 |
| Jefferies | Peter Abramowitz | $107 | $96.2 | -27.6% | Apr 10, 2024 |
| Evercore ISI | Steve Sakawa | $104 | $94.98 | -29.6% | Apr 2, 2024 |
| Raymond James | Analyst unavailable | $113 | $83.27 | -23.5% | Aug 5, 2022 |
| Raymond James | Analyst unavailable | $111 | $83.92 | -24.9% | Apr 26, 2022 |
Track every rating change on CBRE the moment it posts. Free to start.
Start free